DRW8:ETR
Draegerwerk AG & Co KGaA
€77.40
arrow_downward
-0.26%(-0.20) 1D
Nov 6, 5:35:05 PM GMT+1 · EUR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRW8...
Open
€76.80
High
€77.80
Low
€75.40
Mkt. cap
1.65B
Avg. vol.
5.58K
Volume
3.36K
P/E ratio
8.54
52-wk high
€96.00
52-wk low
€55.60
EPS
€9.06
Shares outstanding
10.16M
No. of employees
17K
Open
€76.80
High
€77.80
Low
€75.40
Mkt. cap
1.65B
Avg. vol.
5.58K
Volume
3.36K
P/E ratio
8.54
52-wk high
€96.00
52-wk low
€55.60
EPS
€9.06
Shares outstanding
10.16M
No. of employees
17K
News stories
From web sources and news partners
BigGo Finance
·
13 minutes ago
VIX Jumps 11.57 Points in a Day as S&P 500 Drops 4.41%; Historical Data Shows 79% Positive Returns Six Months Later
www.tmgm.com
·
14 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Bloomberg.com
·
22 hours ago
Watch Stocks Selloff Pauses Rebound After Tech Rout; Jobs Report Ahead
Profile
Drägerwerk AG & Co. KGaA, commonly known as Dräger, is a publicly listed company based in Lübeck, Germany. It develops, manufactures, and sells devices and systems in the fields of medical and safety technology.
Rescue workers in the North American mining industry are often referred to as a Drägerman due to Dräger’s respiratory protection equipment. Wikipedia
About Draegerwerk AG & Co KGaA
CEOStefan Dräger
Employees16.7K
Founded1889
Headquarters-
SectorHealth Care
IndustryMedical device
Websitedraeger.com
Last report
Oct 29, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (EUR)
- GAAP EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
850.77M / 850.80M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in EUR | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 1.14B | 755.87M | 847.31M | 850.77M |
Cost of goods sold | 620.71M | 406.06M | 459.90M | 446.98M |
Cost of revenue | 620.71M | 406.06M | 459.90M | 446.98M |
Research and development expenses | 84.67M | 79.84M | 83.68M | 84.78M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 287.50M | 250.43M | 265.49M | 269.63M |
Operating expense | 377.25M | 331.02M | 349.76M | 354.13M |
Total operating expenses | 997.96M | 737.07M | 809.66M | 801.11M |
Operating income | 140.42M | 18.80M | 37.65M | 49.66M |
Other non operating income | -1.97M | -918.00K | -481.00K | -1.64M |
EBT including unusual items | 148.94M | 15.66M | 42.04M | 46.55M |
EBT excluding unusual items | 143.20M | 15.66M | 34.24M | 46.55M |
Income tax expense | 54.05M | 4.40M | 13.10M | 12.98M |
Effective tax rate | 36.29% | 28.07% | 31.16% | 27.88% |
Other operating expenses | 5.07M | 749.00K | 592.00K | -285.00K |
Net income | 94.65M | 11.44M | 29.52M | 34.00M |
Net profit margin | 8.31% | 1.51% | 3.48% | 4.00% |
Earnings per share | - | - | - | - |
Interest and investment income | 8.45M | 3.01M | 2.15M | 3.52M |
Interest expense | -3.86M | -5.24M | -5.72M | -4.99M |
Net interest expenses | 4.59M | -2.23M | -3.57M | -1.47M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 160.86M | 39.25M | 71.57M | 84.95M |
Gain or loss from assets sale | 318.00K | -8.00K | 47.00K | 224.00K |
Upcoming events